State Offices of Women’s Health Support and Expansion Act
- Sponsor
- Rep. Carter, Troy A. [D-LA-2]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 22, 2026
Bottom line
The bill aims to enhance women's health outcomes nationwide by funding state-level infrastructure for education, data collection, and community engagement, with specific protections for access to comprehensive reproductive health information and services.
What it actually does
This bill establishes a new grant program under the Public Health Service Act, authorizing $55 million annually for fiscal years 2027 through 2031. These grants would enable states to establish or maintain offices of women's health, focusing on public education, addressing social determinants of health, and convening community stakeholder advisory panels. The bill explicitly prohibits the use of funds for activities that discourage reproductive health services or misrepresent medically accurate information.
Proponents argue
Proponents argue that establishing dedicated State Offices of Women's Health is crucial for addressing persistent health disparities and improving health outcomes for women across their lifespan. They contend that a coordinated state-level approach, supported by federal grants, can effectively educate the public on preventive care, manage chronic diseases, and tackle critical issues like maternal mortality and reproductive health, especially in rural and underserved areas. The bill's emphasis on social determinants of health and community stakeholder input is seen as vital for creating responsive and equitable health initiatives.
Opponents contend
Opponents might argue that this bill represents an overreach of federal authority into state health matters, potentially dictating state-level health priorities through funding conditions. Concerns could be raised about the specific prohibitions on fund use, which some may view as infringing on states' abilities to define their own public health messaging or as promoting certain controversial health services. Additionally, some may question the efficiency of creating new state offices rather than bolstering existing health department programs.
The bill is relatively short and clearly structured, making it accessible for an informed reader to understand its core provisions within a reasonable timeframe.
Section 2, inserting new Section 229A(a) and (b) into the Public Health Service Act.
Establishment of State Offices of Women's Health Grant Program
This provision directs the Secretary of Health and Human Services, through the Deputy Assistant Secretary for Women's Health, to award grants to eligible states. These grants are specifically for states to either create new State Offices of Women's Health within their health departments or to support existing ones. States must submit an application to be considered eligible.
Supporters argue
Supporters argue that a dedicated federal grant program is essential to incentivize and support states in prioritizing women's health. This ensures a consistent focus on women's specific health needs, which are often overlooked in broader public health initiatives.
Critics contend
Some might argue that states should fund these offices through their own budgets, or that existing federal block grants could be used, rather than creating a new, specific grant program that could lead to federal overreach in state health policy.
Tradeoffs
The tension lies between federal encouragement and state autonomy in public health. While federal funding can stimulate important initiatives, it also comes with federal requirements and oversight.
Section 2, inserting new Section 229A(c) into the Public Health Service Act.
Activities Supported by Grants
This section outlines the specific activities states can use the grant funds for. These include establishing or maintaining a State office, educating the public on various women's health topics (preventive, reproductive, maternal, chronic disease, health promotion, health disparities), addressing social determinants of health, and establishing a community stakeholder advisory panel to guide strategic priorities.
Section 2, inserting new Section 229A(d) into the Public Health Service Act.
Restrictions on Grant Fund Usage
This crucial provision explicitly forbids states from using grant funds, directly or indirectly, for activities that discourage individuals from seeking reproductive health services (including abortion, contraception, assisted reproductive care, hormone therapy, sex education, STI testing). It also prohibits withholding or misrepresenting scientifically accurate, evidence-based information on contraception, medication abortion, sex education, or general public health information, including vaccines, or restricting access to any lawful health service.
Section 2, inserting new Section 229A(e) into the Public Health Service Act.
Grant Funding Allocation
The bill specifies how the authorized funding will be distributed among eligible states. Half of the funding (50%) will be divided equally among all eligible states, providing a baseline. The other half (50%) will be allocated based on a formula that considers female population, maternal mortality rates, poverty rates among women, and the proportion of the rural population in each state, aiming to direct more funds to states with greater need.
Section 2, inserting new Section 229A(f) into the Public Health Service Act.
Data Privacy Safeguards
This provision establishes strict privacy rules for data collected by State Offices of Women's Health. It prohibits the use of this data with external digital platforms, its use in any civil or criminal legal proceedings, or its disclosure, sale, or sharing in any way that identifies individuals or their healthcare providers.
Section 2, inserting new Section 229A(i) into the Public Health Service Act.
Funding Authorization
This section authorizes the appropriation of $55,000,000 for each of fiscal years 2027 through 2031 to carry out the grant program for State Offices of Women's Health. This sets the maximum amount of funding that Congress can choose to appropriate for this program each year.
This provision allows State Departments of Health, in coordination with State Medicaid agencies, to establish data sharing agreements. The purpose is to exchange high-level, aggregate, de-identified data to identify gaps in women's health services covered by Medicaid and to develop evidence-based proposals for Medicaid waivers or amendments to improve women's health outcomes. Strict privacy protections are mandated, requiring data to be de-identified according to federal standards, aggregated, and used solely for these public health purposes.
Section 2, inserting new Section 229A(g) into the Public Health Service Act.
Why it matters:This is standard legislative practice to include specific technical allowances or exceptions after broader rules, ensuring clarity on permissible actions while maintaining overall restrictions.
Case for: Proponents argue that this targeted data sharing is crucial for evidence-based policymaking, allowing states to identify and address real service gaps in women's health within their Medicaid programs while maintaining robust privacy protections.
Case against: Some privacy advocates might express concern that any data sharing, even de-identified, carries inherent risks, though the bill's explicit adherence to HIPAA de-identification standards and aggregation requirements aims to mitigate this.
Estimated impact: Enables data-driven improvements in women's health services for Medicaid enrollees across participating states, potentially affecting millions.